Systemic Mechanisms in Allergic Rhinitis: Assessment of Metabolomic Outcomes.
Systemic Mechanisms in Allergic Rhinitis: Assessment of Metabolomic Outcomes.
This clinical study will use the Environmental Exposure Unit (EEU) to generate allergic
 rhinitis symptoms in participants under controlled conditions, to collect well-characterized
 biological samples (urine and blood) before and after they develop these symptoms. The EEU
 provides the ability to control the timing, duration and levels of allergen exposure, and
 also other outside environmental factors, yielding ideal biologic samples for analysis with
 novel, cutting-edge molecular techniques. Results from the analysis of these unique allergic
 rhinitis samples should help determine if the technique of urine Nuclear Magnetic Resonance
 analysis could be a useful diagnostic tool in allergic rhinitis. IgE testing will be done on
 blood samples and compared to spin prick testing and symptoms of allergic rhinitis.
Inclusion Criteria:

 -  Participant is a healthy, ambulatory male or female volunteer 18 to 55 years of age.

 -  Participant has a history of Seasonal Allergic Rhinitis due to ragweed for the last
 two consecutive ragweed seasons.

 -  Participant has a positive response (wheal diameter greater than or equal to 3 mm
 larger than diluent control) to a skin prick test to short ragweed allergen at
 screening or within 12 months of screening visit.

 Exclusion Criteria:

 -  Participant is a female that is pregnant, lactating or actively trying to become
 pregnant.

 -  smokers

 -  Participant is unable to comply with the washout periods for prohibited medications.

 -  Participant is currently receiving allergen specific immunotherapy injections.